BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 28270406)

  • 1. AKR1B1 promotes basal-like breast cancer progression by a positive feedback loop that activates the EMT program.
    Wu X; Li X; Fu Q; Cao Q; Chen X; Wang M; Yu J; Long J; Yao J; Liu H; Wang D; Liao R; Dong C
    J Exp Med; 2017 Apr; 214(4):1065-1079. PubMed ID: 28270406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The AKR1B1 inhibitor epalrestat suppresses the progression of cervical cancer.
    Ji J; Xu MX; Qian TY; Zhu SZ; Jiang F; Liu ZX; Xu WS; Zhou J; Xiao MB
    Mol Biol Rep; 2020 Aug; 47(8):6091-6103. PubMed ID: 32761301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FOXF2 deficiency promotes epithelial-mesenchymal transition and metastasis of basal-like breast cancer.
    Wang QS; Kong PZ; Li XQ; Yang F; Feng YM
    Breast Cancer Res; 2015 Feb; 17(1):30. PubMed ID: 25848863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear translocation of PLSCR1 activates STAT1 signaling in basal-like breast cancer.
    Huang P; Liao R; Chen X; Wu X; Li X; Wang Y; Cao Q; Dong C
    Theranostics; 2020; 10(10):4644-4658. PubMed ID: 32292520
    [No Abstract]   [Full Text] [Related]  

  • 5. Twist2 contributes to breast cancer progression by promoting an epithelial-mesenchymal transition and cancer stem-like cell self-renewal.
    Fang X; Cai Y; Liu J; Wang Z; Wu Q; Zhang Z; Yang CJ; Yuan L; Ouyang G
    Oncogene; 2011 Nov; 30(47):4707-20. PubMed ID: 21602879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of UGT8 suppresses basal-like breast cancer progression by attenuating sulfatide-αVβ5 axis.
    Cao Q; Chen X; Wu X; Liao R; Huang P; Tan Y; Wang L; Ren G; Huang J; Dong C
    J Exp Med; 2018 Jun; 215(6):1679-1692. PubMed ID: 29728441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FOXC1 regulates the functions of human basal-like breast cancer cells by activating NF-κB signaling.
    Wang J; Ray PS; Sim MS; Zhou XZ; Lu KP; Lee AV; Lin X; Bagaria SP; Giuliano AE; Cui X
    Oncogene; 2012 Nov; 31(45):4798-802. PubMed ID: 22249250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IMPA2 promotes basal-like breast cancer aggressiveness by a MYC-mediated positive feedback loop.
    Lei X; Liao R; Chen X; Wang Z; Cao Q; Bai L; Ma C; Deng X; Ma Y; Wu X; Li J; Dai Z; Dong C
    Cancer Lett; 2024 Feb; 582():216527. PubMed ID: 38048842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of SDF-1 activates the NF-κB pathway to induce epithelial to mesenchymal transition and cancer stem cell-like phenotypes of breast cancer cells.
    Kong L; Guo S; Liu C; Zhao Y; Feng C; Liu Y; Wang T; Li C
    Int J Oncol; 2016 Mar; 48(3):1085-94. PubMed ID: 26782945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RANK induces epithelial-mesenchymal transition and stemness in human mammary epithelial cells and promotes tumorigenesis and metastasis.
    Palafox M; Ferrer I; Pellegrini P; Vila S; Hernandez-Ortega S; Urruticoechea A; Climent F; Soler MT; Muñoz P; Viñals F; Tometsko M; Branstetter D; Dougall WC; González-Suárez E
    Cancer Res; 2012 Jun; 72(11):2879-88. PubMed ID: 22496457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FOXF2 suppresses the FOXC2-mediated epithelial-mesenchymal transition and multidrug resistance of basal-like breast cancer.
    Cai J; Tian AX; Wang QS; Kong PZ; Du X; Li XQ; Feng YM
    Cancer Lett; 2015 Oct; 367(2):129-37. PubMed ID: 26210254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Twist1 promotes breast cancer invasion and metastasis by silencing Foxa1 expression.
    Xu Y; Qin L; Sun T; Wu H; He T; Yang Z; Mo Q; Liao L; Xu J
    Oncogene; 2017 Feb; 36(8):1157-1166. PubMed ID: 27524420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of EGF-NF-κB-FOXC1 signaling axis in basal-like breast cancer.
    Chung S; Jin Y; Han B; Qu Y; Gao B; Giuliano AE; Cui X
    Cell Commun Signal; 2017 Jun; 15(1):22. PubMed ID: 28629477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression and enhanced specific activity of aldoketo reductases (AKR1B1 & AKR1B10) in human breast cancers.
    Reddy KA; Kumar PU; Srinivasulu M; Triveni B; Sharada K; Ismail A; Reddy GB
    Breast; 2017 Feb; 31():137-143. PubMed ID: 27855345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double-negative feedback loop between ZEB2 and miR-145 regulates epithelial-mesenchymal transition and stem cell properties in prostate cancer cells.
    Ren D; Wang M; Guo W; Huang S; Wang Z; Zhao X; Du H; Song L; Peng X
    Cell Tissue Res; 2014 Dec; 358(3):763-78. PubMed ID: 25296715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VEGF/NRP-1axis promotes progression of breast cancer via enhancement of epithelial-mesenchymal transition and activation of NF-κB and β-catenin.
    Luo M; Hou L; Li J; Shao S; Huang S; Meng D; Liu L; Feng L; Xia P; Qin T; Zhao X
    Cancer Lett; 2016 Apr; 373(1):1-11. PubMed ID: 26805761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reciprocal activation between ATPase inhibitory factor 1 and NF-κB drives hepatocellular carcinoma angiogenesis and metastasis.
    Song R; Song H; Liang Y; Yin D; Zhang H; Zheng T; Wang J; Lu Z; Song X; Pei T; Qin Y; Li Y; Xie C; Sun B; Shi H; Li S; Meng X; Yang G; Pan S; Zhu J; Qi S; Jiang H; Zhang Z; Liu L
    Hepatology; 2014 Nov; 60(5):1659-73. PubMed ID: 25042864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aldo-keto reductase family 1 member B1 inhibitors: old drugs with new perspectives.
    Liu J; Wen G; Cao D
    Recent Pat Anticancer Drug Discov; 2009 Nov; 4(3):246-53. PubMed ID: 19522700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Artichoke Leaf Extract Inhibits AKR1B1 and Reduces NF-κB Activity in Human Leukemic Cells.
    Miláčková I; Kapustová K; Mučaji P; Hošek J
    Phytother Res; 2017 Mar; 31(3):488-496. PubMed ID: 28127803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disrupting the interaction of BRD4 with diacetylated Twist suppresses tumorigenesis in basal-like breast cancer.
    Shi J; Wang Y; Zeng L; Wu Y; Deng J; Zhang Q; Lin Y; Li J; Kang T; Tao M; Rusinova E; Zhang G; Wang C; Zhu H; Yao J; Zeng YX; Evers BM; Zhou MM; Zhou BP
    Cancer Cell; 2014 Feb; 25(2):210-25. PubMed ID: 24525235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.